Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study
Carolina García‐Vidal, Gemma Sanjuan, Estela Moreno-García, et al.
Clinical Microbiology and Infection (2020) Vol. 27, Iss. 1, pp. 83-88
Open Access | Times Cited: 929

Showing 1-25 of 929 citing articles:

Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis
Jackson Musuuza, Lauren Watson, Vishala Parmasad, et al.
PLoS ONE (2021) Vol. 16, Iss. 5, pp. e0251170-e0251170
Open Access | Times Cited: 431
Hospital-Acquired Infections in Critically Ill Patients With COVID-19
Giacomo Grasselli, Vittorio Scaravilli, Davide Mangioni, et al.
CHEST Journal (2021) Vol. 160, Iss. 2, pp. 454-465
Open Access | Times Cited: 317
Ventilator-associated pneumonia in critically ill patients with COVID-19
Mailis Maes, Ellen E. Higginson, Joana Pereira-Dias, et al.
Critical Care (2021) Vol. 25, Iss. 1
Open Access | Times Cited: 285
The role of co-infections and secondary infections in patients with COVID-19
Charles Feldman, Ronald Anderson
Pneumonia (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 275
Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome
Tommaso Bardi, Vicente Pintado, María Gómez Rojo, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2021) Vol. 40, Iss. 3, pp. 495-502
Open Access | Times Cited: 265
COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions?
Amir Arastehfar, Agostinho Carvalho, M. Hong Nguyen, et al.
Journal of Fungi (2020) Vol. 6, Iss. 4, pp. 211-211
Open Access | Times Cited: 244
SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance
Rémy Robinot, Mathieu Hubert, Guilherme Dias de Melo, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 212
The double‐edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza‐associated mucormycosis versus COVID‐19 associated mucormycosis
Kazem Ahmadikia, Seyed Jamal Hashemi, Sadegh Khodavaisy, et al.
Mycoses (2021) Vol. 64, Iss. 8, pp. 798-808
Open Access | Times Cited: 193
Bacterial Coinfections in Coronavirus Disease 2019
Lars F. Westblade, Matthew S. Simon, Michael J. Satlin
Trends in Microbiology (2021) Vol. 29, Iss. 10, pp. 930-941
Open Access | Times Cited: 187
Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications
Fen Zhang, Raphaela Iris Lau, Qin Liu, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 5, pp. 323-337
Open Access | Times Cited: 177
Peptide and peptide-based inhibitors of SARS-CoV-2 entry
Desirée Schütz, Yasser B. Ruiz‐Blanco, Jan Münch, et al.
Advanced Drug Delivery Reviews (2020) Vol. 167, pp. 47-65
Open Access | Times Cited: 167
Increased incidence of candidemia in a tertiary care hospital with the COVID‐19 pandemic
Márcio Nucci, Glória Barreiros, Luiz Felipe Guimarães, et al.
Mycoses (2020) Vol. 64, Iss. 2, pp. 152-156
Open Access | Times Cited: 165
Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance?
Dominique L Monnet, Stephan Harbarth
Eurosurveillance (2020) Vol. 25, Iss. 45
Open Access | Times Cited: 163
The interface between COVID-19 and bacterial healthcare-associated infections
Ronan O’Toole
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 12, pp. 1772-1776
Open Access | Times Cited: 156
State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia
Woon H. Chong, Biplab K. Saha, Ananthakrishnan Ramani, et al.
Infection (2021) Vol. 49, Iss. 4, pp. 591-605
Open Access | Times Cited: 155
Secondary Infections in Hospitalized COVID-19 Patients: Indian Experience
Sonam Vijay, N.K. Bansal, Brijendra Kumar Rao, et al.
Infection and Drug Resistance (2021) Vol. Volume 14, pp. 1893-1903
Open Access | Times Cited: 152
Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands
Zara Karami, Bram T. Knoop, Anton S. M. Dofferhoff, et al.
Infectious Diseases (2020) Vol. 53, Iss. 2, pp. 102-110
Open Access | Times Cited: 150
Characterization of Bacterial and Fungal Infections in Hospitalized Patients With Coronavirus Disease 2019 and Factors Associated With Health Care-Associated Infections
Christine J. Kubin, Thomas H. McConville, Donald Dietz, et al.
Open Forum Infectious Diseases (2021) Vol. 8, Iss. 6
Open Access | Times Cited: 146
Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study
Marco Falcone, Giusy Tiseo, Cesira Giordano, et al.
Journal of Antimicrobial Chemotherapy (2020) Vol. 76, Iss. 4, pp. 1078-1084
Open Access | Times Cited: 142
Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England
Zahin Amin‐Chowdhury, Felicity Aiano, Anna Mensah, et al.
Clinical Infectious Diseases (2020) Vol. 72, Iss. 5, pp. e65-e75
Open Access | Times Cited: 141
Understanding the role of bacterial and fungal infection in COVID-19
Timothy M. Rawson, Richard Wilson, Alison Holmes
Clinical Microbiology and Infection (2020) Vol. 27, Iss. 1, pp. 9-11
Open Access | Times Cited: 140
Characteristics, Outcomes, and Severity Risk Factors Associated With SARS-CoV-2 Infection Among Children in the US National COVID Cohort Collaborative
Blake Martin, Peter DeWitt, Seth Russell, et al.
JAMA Network Open (2022) Vol. 5, Iss. 2, pp. e2143151-e2143151
Open Access | Times Cited: 130
Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit
Alessandro Russo, Francesca Gavaruzzi, Giancarlo Ceccarelli, et al.
Infection (2021) Vol. 50, Iss. 1, pp. 83-92
Open Access | Times Cited: 124
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022)
Adarsh Bhimraj, Rebecca L. Morgan, Amy Hirsch Shumaker, et al.
Clinical Infectious Diseases (2022) Vol. 78, Iss. 7, pp. e250-e349
Open Access | Times Cited: 120
COVID-19 and antimicrobial resistance: A cross-study
Sidra Ghazali Rizvi, Shaikh Ziauddin Ahammad
The Science of The Total Environment (2021) Vol. 807, pp. 150873-150873
Open Access | Times Cited: 119
Page 1 - Next Page

Scroll to top